Debt to Assets Ratio: 57.99%
Is the debt to assets ratio high or low?
The debt to assets ratio of 57.99% is 81% above its 5-year average of 32.07%, near the high end of its 5-year range (14.94%–58.97%).
As of Saturday, June 27, 2026. 3.17% above its 12-month average of 56.21%.
NRC Debt to Assets Ratio
Reported quarterly debt to assets ratio; no daily interpolation.
NRC Average Debt to Assets Ratio Chart
NRC Current vs Average Debt to Assets Ratio Chart
NRC Debt to Assets Ratio Metrics
DEBT TO ASSETS RATIO
57.99%
DEBT TO ASSETS RATIO AVG TTM
56.21%
DEBT TO ASSETS RATIO AVG 3Y
40.26%
DEBT TO ASSETS RATIO AVG 5Y
32.07%
DEBT TO ASSETS RATIO AVG 10Y
24.91%
DEBT TO ASSETS RATIO AVG 15Y
18.99%
DEBT TO ASSETS RATIO AVG 20Y
14.15%
CURRENT VS TTM AVG
+3.17%
CURRENT VS 3Y AVG
+44.04%
CURRENT VS 5Y AVG
+80.84%
CURRENT VS 10Y AVG
+132.79%
CURRENT VS 15Y AVG
+205.33%
CURRENT VS 20Y AVG
+309.97%
NRC Competitors' Debt to Assets Ratio
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| National Research Corporation (NRC) | $468.99M | 57.99% | 56.21% | 40.26% | 32.07% |
| Shoulder Innovations, Inc. (SI)vs › | $472.62M | 0.09% | N/A | N/A | N/A |
| 23andMe Holding Co. (ME)vs › | $15.31M | 0.43% | N/A | N/A | N/A |
| Teladoc Health, Inc. (TDOC)vs › | $1.51B | 0.34% | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | 0.45% | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.37B | 0.44% | N/A | N/A | N/A |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.56B | 0.52% | N/A | N/A | N/A |
| Oscar Health, Inc. (OSCR)vs › | $7.72B | 0.07% | N/A | N/A | N/A |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.13B | 0.14% | N/A | N/A | N/A |
| Universal Health Services, Inc. (UHS)vs › | $9.12B | 0.35% | N/A | N/A | N/A |
Leverage Ratios Comparison
Debt/Assets
58.0%
Debt/Equity
5.65
Current Ratio
0.55
Interest Coverage
4.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
- Debt/Assets: Shows % of assets funded by creditors (bounded 0-100%)
- Debt/Equity: Shows debt relative to shareholder investment (can exceed 100%)
- Both measure leverage but from different perspectives
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt to Assets Ratio Formula & Definition
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Debt to Assets Ratio FAQ
- What is the debt to assets ratio for National Research Corporation (NRC)?
- The debt to assets ratio for NRC stock is 57.99%.
- Is National Research Corporation's debt to assets ratio high or low?
- The debt to assets ratio of 57.99% is 81% above its 5-year average of 32.07%, near the high end of its 5-year range (14.94%–58.97%).
- What is the TTM average debt to assets ratio for National Research Corporation (NRC)?
- The TTM average debt to assets ratio for NRC stock is 56.21%.
- What is the 3Y average debt to assets ratio for National Research Corporation (NRC)?
- The 3Y average debt to assets ratio for NRC stock is 40.26%.
- What is the 5Y average debt to assets ratio for National Research Corporation (NRC)?
- The 5Y average debt to assets ratio for NRC stock is 32.07%.
- What is the 10Y average debt to assets ratio for National Research Corporation (NRC)?
- The 10Y average debt to assets ratio for NRC stock is 24.91%.
- What is the 15Y average debt to assets ratio for National Research Corporation (NRC)?
- The 15Y average debt to assets ratio for NRC stock is 18.99%.
- What is the 20Y average debt to assets ratio for National Research Corporation (NRC)?
- The 20Y average debt to assets ratio for NRC stock is 14.15%.
NRC Debt to Assets Ratio History
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-03-31 | 57.99% |
| 2025-12-31 | 58.60% |
| 2025-09-30 | 58.97% |
| 2025-06-30 | 57.26% |
| 2025-03-31 | 48.24% |
| 2024-12-31 | 48.60% |
| 2024-09-30 | 40.69% |
| 2024-06-30 | 35.45% |
| 2024-03-31 | 34.80% |
| 2023-12-31 | 32.31% |
| 2023-09-30 | 19.84% |
| 2023-06-30 | 14.94% |
| 2023-03-31 | 15.69% |
| 2022-12-31 | 17.93% |
| 2022-09-30 | 17.24% |
| 2022-06-30 | 17.94% |
| 2022-03-31 | 16.65% |
| 2021-12-31 | 18.20% |
| 2021-09-30 | 19.24% |
| 2021-06-30 | 20.63% |
| 2021-03-31 | 22.22% |
| 2020-12-31 | 24.91% |
| 2020-09-30 | 27.03% |
| 2020-06-30 | 30.50% |
| 2020-03-31 | 30.59% |
| 2019-12-31 | 33.09% |
| 2019-09-30 | 32.62% |
| 2019-06-30 | 35.51% |
| 2019-03-31 | 37.00% |
| 2018-12-31 | 3.41% |
| 2018-09-30 | 35.81% |
| 2018-06-30 | 38.58% |
| 2018-03-31 | 0.04% |
| 2017-12-31 | 0.84% |
| 2017-09-30 | 1.38% |
| 2017-06-30 | 1.77% |
| 2017-03-31 | 2.24% |
| 2016-12-31 | 2.22% |
| 2016-09-30 | 2.06% |
| 2016-06-30 | 3.97% |
| 2016-03-31 | 4.40% |
| 2015-12-31 | 1.86% |
| 2015-09-30 | 4.95% |
| 2015-06-30 | 5.36% |
| 2015-03-31 | 5.93% |
| 2014-12-31 | 1.80% |
| 2014-09-30 | 1.82% |
| 2014-06-30 | 7.69% |
| 2014-03-31 | 8.56% |
| 2013-12-31 | 2.03% |
| 2013-09-30 | 10.00% |
| 2013-06-30 | 11.17% |
| 2013-03-31 | 11.80% |
| 2012-12-31 | 12.43% |
| 2012-09-30 | 11.95% |
| 2012-06-30 | 1.98% |
| 2012-03-31 | 2.00% |
| 2011-12-31 | 14.71% |
| 2011-09-30 | 1.86% |
| 2011-06-30 | 3.25% |
| 2011-03-31 | 16.03% |
| 2010-12-31 | 16.87% |
| 2010-09-30 | 1.94% |
| 2010-06-30 | 1.04% |
| 2010-03-31 | 1.04% |
| 2009-12-31 | 10.65% |
| 2009-09-30 | 1.03% |
| 2009-06-30 | 1.13% |
| 2009-03-31 | 15.01% |
| 2008-12-31 | 17.96% |
| 2008-09-30 | 0.39% |
| 2008-06-30 | 5.32% |
| 2008-03-31 | 10.64% |
| 2007-12-31 | 4.84% |
| 2007-09-30 | 7.52% |
| 2007-06-30 | 10.69% |
| 2007-03-31 | 13.33% |
| 2006-12-31 | 18.03% |
| 2006-09-30 | 4.98% |
| 2006-06-30 | 20.57% |
| 2006-03-31 | 0.45% |
| 2005-12-31 | 3.29% |
| 2005-09-30 | 9.72% |
| 2005-06-30 | 9.97% |
| 2005-03-31 | 9.98% |
| 2004-12-31 | 10.22% |
| 2004-09-30 | 10.68% |
| 2004-06-30 | 10.67% |
| 2004-03-31 | 10.83% |
| 2003-12-31 | 11.04% |
| 2003-09-30 | 11.70% |
| 2003-06-30 | 11.84% |
| 2003-03-31 | 12.29% |
| 2002-12-31 | 13.33% |
| 2002-09-30 | 13.97% |
| 2002-06-30 | 14.61% |
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green